glp-1 drugs safe Medications Clinic Near Me in Fayetteville, NC Researchers find GLP-1 medications safe

Shu X, Zhang Y, Li M, et al

Results Patients lose an average of 10-15% of body weight over 68 weeks in registration trials for FDA-approved formulations

Same goal, different paths

Originally designed to manage type 2 diabetes (T2D), these drugs have rapidly expanded their therapeutic reach, offering significant benefits for obesity, cardiovascular disease, and beyond

Supply chain: Compounded tirzepatide availability depends on the FDA shortage list

The figure depicts the gap in % between the optimal allocation strategy between new and existing patients (which can be quite complex) and strategies (Myopic and Safety-Stock) that are easy to implement